![David Epstein](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Epstein
Founder at
Pairx Bio Pte Ltd.
Net worth: - $ as of 31/07/2026
Profile
David M.
Epstein was the founder of Archemix Corp., founded in 2001, where the title held was Vice President-Biology from 2001 to 2003.
Dr. Epstein was the founder of Black Diamond Therapeutics, Inc., founded in 2014, holding the title of Director from 2023 to 2024.
Dr. Epstein is the founder of Pairx Bio Pte Ltd., founded in 2022, currently serving as President, Chief Executive Officer & Director since 2023.
The current job is Independent Director at Gyre Therapeutics, Inc. starting in 2024.
Former jobs include Director at MetaStat, Inc. from 2013 to 2015, Chief Scientific Officer-Oncology & Senior VP at OSI Pharmaceuticals, Inc. from 2006 to 2013, and Associate Professor at Duke-NUS Graduate Medical School Singapore.
Education includes a doctorate from Brandeis University and an undergraduate degree from Lewis & Clark College (Oregon).
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
-.--% | 10/06/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
David Epstein active positions
| Companies | Position | Start |
|---|---|---|
Pairx Bio Pte Ltd.
 Pairx Bio Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Operates a biotechnology company which develops and generates cancer immunotherapies targeting shared tumor-associated antigens derived from aberrantly spliced proteins | Founder | 01/06/2022 |
Former positions of David Epstein
| Companies | Position | End |
|---|---|---|
| BLACK DIAMOND THERAPEUTICS, INC. | Founder | 01/06/2024 |
| METASTAT, INC. | Director/Board Member | 01/04/2015 |
| OSI PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 31/03/2013 |
Archemix Corp.
 Archemix Corp. Miscellaneous Commercial ServicesCommercial Services Provides molecular biology research to develop new drugs | Founder | 01/01/2003 |
Duke-NUS Graduate Medical School Singapore
 Duke-NUS Graduate Medical School Singapore Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Training of David Epstein
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
58
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
OSI Pharmaceuticals, Inc.
 OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical drugs | Health Technology |
Archemix Corp.
Archemix Corp. Miscellaneous Commercial ServicesCommercial Services Provides molecular biology research to develop new drugs | Commercial Services |
Brandeis University
 Brandeis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lewis & Clark College (Oregon)
 Lewis & Clark College (Oregon) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Duke-NUS Graduate Medical School Singapore
Duke-NUS Graduate Medical School Singapore Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MetaStat, Inc.
 MetaStat, Inc. Electrical ProductsProducer Manufacturing Develops cancer diagnostics technologies | Producer Manufacturing |
Black Diamond Therapeutics, Inc.
 Black Diamond Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops precision medicines for cancer | Health Technology |
Pairx Bio Pte Ltd.
Pairx Bio Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Operates a biotechnology company which develops and generates cancer immunotherapies targeting shared tumor-associated antigens derived from aberrantly spliced proteins | Commercial Services |
- Stock Market
- Insiders
- David Epstein
